PRAME 300–309 (HLA-A*02:01)

PRAME 300–309 (HLA-A*02:01)
€115.00 *

Prices plus VAT plus shipping costs

Delivery time 2-3 days
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Amount in mg:

5 mg

  • EP11397_5
ALYVDSLFFL is a linear peptidic epitope (epitope ID225231) studied as part of Melanoma antigen... more
Product information "PRAME 300–309 (HLA-A*02:01)"

ALYVDSLFFL is a linear peptidic epitope (epitope ID225231) studied as part of Melanoma antigen preferentially expressed in tumors from Homo sapiens (human), tested in T cell assays. Antigen Peptide PRAME 300–309 (HLA-A*02:01) ALYVDSLFFL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.


 
Sequence:ALYVDSLFFL
Gene:PRAME
Delivery:2-3 days
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:5 mg
Counter Ion:TFA
Protein:Melanoma antigen preferentially expressed in tumors
Species:Human
Allele:HLA-A*02:01
Application :Flow Cytometry
Indication :Cancer
PLP (180 - 199) PLP (180 - 199)
From €115.00 *
P60 217-225 (H-2Kd) P60 217-225 (H-2Kd)
From €57.50 *
SNTB2 (351-360) SNTB2 (351-360)
From €57.50 *
Viewed